Bioartificial Organ Manufacturing Market Application,Trends, Demand, Growth, Challenges and Competitive Outlook

4 min readJan 23, 2023

Data Bridge Market Research analyses that the bioartificial organ manufacturing market which was USD 23.13 billion in 2022, is expected to reach USD 42.03 billion by 2030, at a CAGR of 7.75% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

All these factors are of utmost importance when it comes to achieving a success in the competitive marketplace. Thus, the study of Global Bioartificial Organ Manufacturing Market report helps businesses to define their own strategies about the improvement in the existing product, modifications to consider for the future product, sales, marketing promotion and distribution of the product in the existing and the new market.

Get a PDF Sample of the Global Bioartificial Organ Manufacturing Market@

Healthcare surgery treatment for patients with tissue loss or end-stage organ failure is becoming more common as the global population ages and pathologies limit or affect organ functionality progress. According to the American Transplant Foundation, there are approximately 114,000 people on the waiting list for organ transplantation, with approximately 20 deaths due to organ shortages. With such an increase in demand for organ transplants, the market is expected to expand significantly as bioartificial organs help to alleviate donor organ shortages.

Bioartificial organ manufacturing technologies are a series of enabling techniques that can produce human organs based on bionic principles. Organ manufacturing technologies can be divided into three main groups: (1) fully automated, (2) semi-automated, and (3) handworked (or handmade). One of the most promising bioartificial organ manufacturing technologies is combining multi-nozzle three-dimensional printing techniques to assemble personal cells and other biomaterials to build exclusive organ substitutes for defective/failed human organs.


• Increased R&D activities

Factors such as increased product launches increased R&D activities, and key market players’ strategies will drive the growth of the studied segment. Furthermore, the segment’s growth is expected to be fuelled by new product approvals and ongoing government support. In February 2020, the U.S. Food and Drug Administration (FDA) granted Abbott Breakthrough Device designation for its in-development fully implantable left ventricular assist system. In March 2021, Penn State Health Milton S. Hershey Medical Center became the country’s second hospital to implant a newly designed EvaHeart2 Left Ventricular Assist System (LVAS) in a patient with severe heart failure. These all are certain factors that propel the growth of the market.

• Increasing prevalence of organ failure

The rising prevalence of organ failure caused by severe infections, cardiovascular disease, and trauma increases the number of organ transplant surgeries. In 2019, the World Health Organization reported approximately 48.9 million cases of sepsis. Adopting bad habits like drinking and smoking leads to liver and heart failure. As the prevalence of such illnesses rises, so does the risk of organ failure, driving up demand for bioartificial organs.

Download the Complete Research Study Here in PDF Format @

Global Bioartificial Organ Manufacturing Market Scope

The bioartificial organ manufacturing market is segmented on the basis of degree of automation, materials, and process. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Degree of Automation

  • Semi- Automated
  • Fully Automated
  • Handworked


  • Mechanical
  • Biomechanical
  • Biological


  • Architectural Predesign
  • Preparation of Materials and Construction Tools
  • Homogeneous/Heterogeneous Cell Assembling
  • Post Multi-Tissue Maturation

Some of the major players operating in the bioartificial organ manufacturing market are:

  • B. Braun SE (Germany)
  • Boston Scientific Corporation (U.S.)
  • Getinge AB. (Sweden)
  • ABIOMED. (U.S.)
  • Asahi Kasei Corporation (Japan)
  • Berlin Heart (Gemany)
  • CARMAT (France)
  • Jarvik Heart, Inc. (U.S.)
  • Terumo Corporation (Japan)
  • SynCardia Systems, LLC (U.S.)
  • Nipro Europe Group Companies (Japan)
  • Medtronic (U.S.)
  • Organovo Holdings Inc. (U.S.)
  • NexImmune (U.S.)
  • Diabeloop SA (France)
  • Admetsys (U.S.)
  • Defymed (France)
  • Pancreum, Inc. (U.S.)
  • Beta Bionics Inc. (U.S.)
  • Integra LifeSciences (U.S.)

Browse a Detailed Summary of the Research Report @

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475